Crinetics Pharmaceuticals Inc (CRNX) — Long-term Investment Intensity
Crinetics Pharmaceuticals Inc (CRNX) has a Long-term Investment Intensity of 0.1% as of December 2023. Long-term investments of $470.00K represent 0.1% of total assets of $635.35 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CRNX total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Crinetics Pharmaceuticals Inc Long-term Investment Intensity (2021–2023)
This chart shows how Crinetics Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2021 to 2023. As of December 2023, the intensity stands at 0.1%, reflecting long-term investments of $470.00K against total assets of $635.35 Million USD. Also explore CRNX total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Crinetics Pharmaceuticals Inc (2021–2023)
The table below presents the year-by-year Long-term Investment Intensity for Crinetics Pharmaceuticals Inc from 2021 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CRNX market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.1% | $470.00K | $635.35 Million | ▼ -0.2 pp |
| 2021 | 0.3% | $1.01 Million | $351.01 Million | — |